Literature DB >> 23698634

Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.

Shinzo Yamamoto1, Keisuke Tateishi, Yotaro Kudo, Keisuke Yamamoto, Takayuki Isagawa, Genta Nagae, Takuma Nakatsuka, Yoshinari Asaoka, Hideaki Ijichi, Yoshihiro Hirata, Motoyuki Otsuka, Tsuneo Ikenoue, Hiroyuki Aburatani, Masao Omata, Kazuhiko Koike.   

Abstract

Alterations in genes coding for histone modifiers are found in human cancers, suggesting that histone modification is involved in malignant features of neoplastic cells. This study showed that a histone demethylase KDM4C is significant for colonosphere formation by mediating the cross talk between oncogenic pathways through a feed-forward mechanism. The expression of KDM4C gene was increased in spheres from colorectal cancer (CRC) cells and the knockdown (KD) of KDM4C eliminated colonosphere formation. We found that the KD of β-catenin, an important oncogenic factor in CRC, resulted in not only decreased sphere formation but also impaired upregulation of KDM4C gene in spheres. β-Catenin bound to the KDM4C promoter, suggesting that KDM4C is involved in the sphere-forming ability downstream of β-catenin in CRC cells. Microarray analysis identified the JAG1 gene that codes for a notch ligand Jagged1 responsible for sphere formation as a target of KDM4C. KDM4C KD decreased the expression of JAG1 gene, and the downregulation of JAG1 gene recapitulated the impaired colonosphere formation. JAG1 is also a target of β-catenin, and chromatin immunoprecipitation analysis showed the binding of β-catenin and KDM4C onto the JAG1 promoter during colonosphere formation. Importantly, KDM4C KD ruined the recruitment of β-catenin onto the JAG1 promoter independently of the H3-K9 methylation status and blunted JAG1 expression during sphere formation. These data indicate that KDM4C maintains the sphere-forming capacity in CRCs by mediating the β-catenin-dependent transcription of JAG1 in a feed-forward manner.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698634     DOI: 10.1093/carcin/bgt174

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

1.  Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Andreana Holowatyj; Xiu-E Xu; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Shao-Hong Wang; En-Min Li; Zeng-Quan Yang; Li-Yan Xu
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

2.  Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.

Authors:  Young K Chen; Tiziana Bonaldi; Alessandro Cuomo; Joselyn R Del Rosario; David J Hosfield; Toufike Kanouni; Shih-Chu Kao; Chon Lai; Neethan A Lobo; Jennifer Matuszkiewicz; Andrew McGeehan; Shawn M O'Connell; Lihong Shi; Jeffrey A Stafford; Ryan K Stansfield; James M Veal; Michael S Weiss; Natalie Y Yuen; Michael B Wallace
Journal:  ACS Med Chem Lett       Date:  2017-07-27       Impact factor: 4.345

3.  Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.

Authors:  T Nakatsuka; K Tateishi; Y Kudo; K Yamamoto; H Nakagawa; H Fujiwara; R Takahashi; K Miyabayashi; Y Asaoka; Y Tanaka; H Ijichi; Y Hirata; M Otsuka; M Kato; J Sakai; M Tachibana; H Aburatani; Y Shinkai; K Koike
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

4.  Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.

Authors:  Yaohui Chen; Runping Fang; Chen Yue; Guoqiang Chang; Peng Li; Qing Guo; Jing Wang; Aidong Zhou; Sicong Zhang; Gregory N Fuller; Xiaobing Shi; Suyun Huang
Journal:  Cancer Res       Date:  2019-12-30       Impact factor: 12.701

5.  Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Authors:  Tae-Dong Kim; James R Fuchs; Eric Schwartz; Dalia Abdelhamid; Jonathan Etter; William L Berry; Chenglong Li; Michael A Ihnat; Pui-Kai Li; Ralf Janknecht
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

6.  LGR4/GPR48 inactivation leads to aniridia-genitourinary anomalies-mental retardation syndrome defects.

Authors:  Tingfang Yi; Jinsheng Weng; Stefan Siwko; Jian Luo; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

7.  Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.

Authors:  Marie-Claude Gingras; Kyle R Covington; David K Chang; Lawrence A Donehower; Anthony J Gill; Michael M Ittmann; Chad J Creighton; Amber L Johns; Eve Shinbrot; Ninad Dewal; William E Fisher; Christian Pilarsky; Robert Grützmann; Michael J Overman; Nigel B Jamieson; George Van Buren; Jennifer Drummond; Kimberly Walker; Oliver A Hampton; Liu Xi; Donna M Muzny; Harsha Doddapaneni; Sandra L Lee; Michelle Bellair; Jianhong Hu; Yi Han; Huyen H Dinh; Mike Dahdouli; Jaswinder S Samra; Peter Bailey; Nicola Waddell; John V Pearson; Ivon Harliwong; Huamin Wang; Daniela Aust; Karin A Oien; Ralph H Hruban; Sally E Hodges; Amy McElhany; Charupong Saengboonmee; Fraser R Duthie; Sean M Grimmond; Andrew V Biankin; David A Wheeler; Richard A Gibbs
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

8.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23

9.  Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth.

Authors:  Brittany L Gregory; Vivian G Cheung
Journal:  Genome Res       Date:  2013-11-27       Impact factor: 9.043

10.  A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Xiu-E Xu; Bo Chen; Shao-Hong Wang; En-Min Li; Li-Yan Xu
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.